Elehear Alpha vs Resound Vivia 9 60S microRIE

The Elehear Alpha is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.4/5 in HearAdvisor's lab testing. At $299, this behind-the-ear device sits in the lower price tier of the OTC category and delivers a performance profile with notable strengths and weaknesses. The Alpha's standout feature is its music streaming quality, scoring a strong 4.2/5—a full 2.28 points above the OTC category average. This makes it an unusually capable choice for users who prioritize audio entertainment alongside hearing assistance. Feedback handling is also excellent at 5.0/5, meaning you're unlikely to experience whistling or squealing during normal use. However, speech clarity presents challenges. Speech in quiet scores a mixed 2.1/5, falling 0.73 points below the category average, while speech in noise is low at 1.0/5, sitting 0.48 points below average. Own-voice comfort is particularly weak at 0.7/5, measuring 1.81 points below the category average—users may notice their own voice sounds unnatural or boomy. Within the same price range, several alternatives offer stronger overall performance, including the Elehear Beyond (4.36/5), Apple AirPods Pro 2 (4.06/5), and Zepp Clarity Omni (3.88/5). The Alpha may appeal to budget-conscious users who primarily want reliable music streaming and stable feedback performance, but those prioritizing speech understanding should consider higher-scoring options.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.